Last updated on December 2008

Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain


Brief description of study

Hair loss occurs commonly as a result of radiotherapy administered to the brain, and this can contribute to the distress and social isolation of patients with advanced cancer. In this study a topical gel will be applied directly to the scalp during each dose of radiotherapy. The goal is to determine to what extent the experimental drug is successful in lessening the hair loss.

Clinical Study Identifier: NCT00801086

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Baldassarre Stea, MD,PhD

University of Arizona
Tucson, AZ United States
  Connect »

Jim Metz, MD

University of Pennsylvania
Philadelphia, PA United States
  Connect »